POMDOCTOR Business Summary

POMDOCTOR Ltd (POM) operates a comprehensive digital healthcare ecosystem in China, primarily focused on chronic disease management through its integrated "Internet Hospital" and "Pharmaceutical Supply Chain" segments. The company generates the majority of its revenue—approximately 75%—from the retail and wholesale distribution of prescription drugs, supplemented by sales of over-the-counter (OTC) medicines, traditional Chinese medicine, and medical apparatus. Its service-based revenue is driven by transaction fees from online follow-up consultations and digital prescription renewal services that connect a network of over 212,000 contracted doctors with nearly 700,000 transacting patients. Within the hyper-competitive Chinese telehealth market, POMDOCTOR positions itself as a specialized mid-tier player, currently ranked as the sixth-largest internet hospital platform by doctor count, trailing dominant industry leaders such as Ping An Good Doctor, AliHealth (Alibaba), and JD Health. The company is led by Co-Founder, Chairman, and CEO Zhenyang Shi, a clinical medicine graduate from BengBu Medical College with an EMBA from China Europe International Business School (CEIBS) and over a decade of experience in pharmaceutical e-commerce. He is supported by Co-Founder and CFO Li Xu, who also holds a clinical medicine background and previously managed the company’s pharmaceutical retail operations. Vice President Guoji Luo, an expert in IT and logistics, oversees the platform’s technical infrastructure and supply chain integration. Following its $20 million NASDAQ IPO in October 2025, the company expanded its board to include independent directors with significant institutional pedigree, including Yuanyuan Jing (Managing Director at Galaxy Capital), Wenqing Bao, and Daxue Li (former Senior VP at JD Group). This leadership team is currently focused on leveraging strategic partnerships with major pharmaceutical manufacturers to transition the firm toward a higher-margin, service-oriented profitability model.